Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORKA | CRNX | STVN | ||
| Company | Oruka Therapeutics Inc | Crinetics Pharmaceuticals Inc | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 106.02 | 84.38 | 21.46 | ||
| High | 111.37 | 84.70 | 21.55 | ||
| Low | 105.10 | 84.36 | 20.97 | ||
| Last | 111.04 | 84.70 | 21.06 | ||
| Change | +2.92 | +0.26 | -0.46 | ||
| Percent Change | +2.70% | +0.31% | -2.14% | ||
| Volume | 1,047,400 | 2,279,000 | 445,300 | ||
| 20-Day Average Volume | 792,040 | 2,614,655 | 434,135 | ||
| Previous | 108.12 | 84.44 | 21.52 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 97.47 | 83.97 | 20.17 | ||
| 20-Day Raw Stochastic | 98.74% | 99.19% | 80.50% | ||
| 20-Day Relative Strength | 70.68 | 87.81 | 60.41 | ||
| Weighted Alpha | +543.76 | +50.86 | +2.50 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.37% since 08/07/26 | +0.74% since 08/07/26 | +3.90% since 08/07/26 | ||
| Low | 95.50 on 08/10/26 | 83.96 on 08/10/26 | 19.99 on 08/10/26 | ||
| High | 111.37 on 08/14/26 | 84.71 on 08/13/26 | 21.61 on 08/13/26 | ||
| 1-Month | |||||
| %Chg | +26.95% since 07/14/26 | +1.18% since 07/14/26 | +6.26% since 07/14/26 | ||
| Low | 80.72 on 07/17/26 | 83.47 on 07/31/26 | 18.74 on 07/16/26 | ||
| High | 111.37 on 08/14/26 | 84.71 on 08/13/26 | 21.61 on 08/13/26 | ||
| 3-Month | |||||
| %Chg | +73.77% since 05/14/26 | +121.09% since 05/14/26 | +17.07% since 05/14/26 | ||
| Low | 53.62 on 06/01/26 | 32.30 on 06/02/26 | 16.27 on 06/16/26 | ||
| High | 111.37 on 08/14/26 | 84.71 on 08/13/26 | 21.61 on 08/13/26 | ||
| 6-Month | |||||
| %Chg | +244.74% since 02/13/26 | +98.36% since 02/13/26 | +31.54% since 02/13/26 | ||
| Low | 31.08 on 02/19/26 | 32.30 on 06/02/26 | 12.89 on 03/27/26 | ||
| High | 111.37 on 08/14/26 | 84.71 on 08/13/26 | 21.61 on 08/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,351,958 | 8,983,706 | 6,377,873 | ||
| Shares Outstanding, K | 66,210 | 106,065 | 302,843 | ||
| Annual Sales, $M | 0 | 7,700,000 | 1,342,160,000 | ||
| Annual Net Income, $M | -105,430,000 | -465,320,000 | 158,210,000 | ||
| Last Qtr Sales, $M | 0 | 25,120,000 | 351,140,000 | ||
| Last Qtr Income, $M | -31,820,000 | -120,860,000 | 26,690,000 | ||
| 60-Month Beta | -0.34 | 0.12 | 0.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 08/10/26 | -1.14 on 08/03/26 | 0.16 on 08/04/26 | ||
| Latest Earnings Date | 11/11/26 | 11/05/26 | 11/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 32.61 | ||